Chapter 13 - Therapeutic role of melatonin in migraine prophylaxis: Is there a link between sleep and migraine?
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) is a prevalent molecule found in almost all living organisms, including bacteria, algae, fungi, plants, insects, and vertebrates (Reiter et al., 2010). In vertebrates, melatonin is produced in the pineal gland and released in the blood. In humans, it is associated with a variety of functions, including circadian regulation, immune function, tumor inhibition, antioxidant activity, free radical scavenging, and antinociception (Blask et al., 2002; Dubocovich et al., 1999; Malpaux et al., 2001). Lower than normal levels of melatonin have been reported in cases of Parkinson's disease, Alzheimer's disease, insomnia, epilepsy, ischemic injury, and various psychiatric disorders (Shimozuma et al., 2011; Wehr et al., 2001), suggesting that it may play important roles in these disorders. Melatonin is known to exert antioxidative, anxiolytic, analgesic, antihypertensive, anti-inflammatory, and oncostatic effects (Wilhelmsen et al., 2011).
Recently, it has been shown that melatonin plays a key role in the endogenous circadian rhythm of humans, via light stimulation in the hypothalamus. Sleep is controlled by a circadian rhythm and normally occurs at night, usually coinciding with nocturnal melatonin secretion (Rodenbeck et al., 1999). Thus, melatonin is a facilitator of sleep in humans and may be useful for treating sleep disorders. There is evidence that melatonin administration can induce sleep in cases with an insufficient sleep drive and can be used to induce phase shifts in the circadian clock to desired times. An antinociceptive role of melatonin also has been reported: exogenous melatonin is effective in relieving chronic pain and treating migraine (Kaur and Shyu, 2018; Wilhelmsen et al., 2011). In this chapter, we describe the latest findings related to melatonin with respect to the physiology of migraine and sleep and discuss the potential utility of melatonin in the treatment of migraine and sleep disorders.
Section snippets
Migraine and sleep disorders
Sleep is a major issue in the lives of people affected by migraine, and sleep disturbances are generally regarded as a trigger factor of a migraine attack. Various symptoms and circumstances can serve as such a trigger: insufficient sleep, disturbed sleep, oversleeping, keeping late hours, rising earlier than usual, irregular sleep cycles due to shift working, or jet lag. Indeed, a meta-analysis revealed that sleep was the second most common trigger factor (after stress) in primary headache
Pathophysiology of comorbidity between migraine and sleep disorders
A complex relationship between migraine and sleep has been reported. Migraine shows a bidirectional comorbidity with insomnia, suggesting shared pathophysiologic mechanisms (Odegard et al., 2011, Odegard et al., 2013). Although the relationship between migraine and sleep problems vary, anatomical locations and roles of signaling molecules (neurotransmitters, neuropeptides and hormones) are common (Vgontzas and Pavlovic, 2018).
Melatonin could play an important role in the significant association
Melatonin synthesis and release
Melatonin is mainly synthesized by pinealocytes, which are cells in the pineal gland that are under the control of the suprachiasmatic (SCN) nucleus of the hypothalamus. Melatonin synthesis begins from tryptophan, which is transformed to 5-hydroxytryptophan by the enzyme tryptophan hydroxylase. After transformation, it is converted into serotonin by the action of aromatic l-amino acid decarboxylase. Serotonin is then converted into N-acetyl serotonin by N-acetyltransferase (AANAT), which is
Safety and adverse effects of melatonin
Melatonin is a relatively safe and nontoxic molecule safe for short-term use (Buscemi et al., 2006). Animal studies have reported no adverse effects or death at a dose of 200 mg/kg in pregnant rats and 800 mg/kg in mice (Makay, 2009). In clinical studies, daily administration of 1000 mg/day melatonin for 1 month led to minor side effects including drowsiness, headache, dizziness, and nausea. Administration of high melatonin doses in healthy volunteers did not impair memory or visual sensitivity.
Melatonin in migraine pathophysiology
Melatonin may play a role in migraine pathophysiology in several ways. Neurogenic inflammation is an important process in the development of migraine (Ramachandran, 2018). Melatonin has anti-inflammatory effects.
Melatonin exerts anti-inflammatory actions in various ways. It inhibits the synthesis of prostaglandin E, decreasing inflammation in the trigeminovascular system (Gimeno et al., 1980). It prevents the translocation of nuclear factor kappa B to the nucleus, which reduces the upregulation
Effects of exogenous melatonin on migraine
To date, seven studies have investigated the effects of exogenous melatonin in the treatment of migraine, including four randomized controlled studies (Alstadhaug et al., 2010; Ebrahimi-Monfared et al., 2017; Fallah et al., 2018; Goncalves et al., 2016) and three observational studies (Bougea et al., 2016; Miano et al., 2008; Peres et al., 2004). Among the four controlled trials, three were double-blinded studies and one was a single-blinded study. One double-blind study evaluated adjunctive
Conclusions and future directions
Melatonin plays important roles in the pathophysiology of migraine and sleep disorders. Migraine and sleep disorders have shown significant associations in clinical and epidemiological studies. Recent studies have shown that exogenous melatonin may be effective at treating both disorders. Therefore, melatonin has promising therapeutic potential for the treatment of these disorders, especially when they are combined. Nevertheless, there are several points that need to be clarified with further
Source of funding/support
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1F1A1053841).
Disclosure
TJS and BSK declare that there are no conflicts of interest regarding this submission. MKC is a site investigator for a multi-center trial sponsored by Otsuka Korea, Novartis International AG, and Eli Lilly and Company. He has served as an advisory member for Teva and received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company in the past 24 months. He received grants from Yonsei University College of Medicine (2018-32-0037) and National Research Foundation of
Authors' contributions
T.J.S. and B.S.K. acquired and analyzed the data and drafted the manuscript; M.K.C. conceptualized the study, analyzed the data, and revised the manuscript.
References (125)
- et al.
Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats
Eur. J. Pharmacol.
(2007) - et al.
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Sleep Med. Rev.
(2017) - et al.
Does melatonin modulate beta-endorphin, corticosterone, and pain threshold?
Life Sci.
(2000) - et al.
Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans
Brain Res.
(1995) Melatonin receptors: role on sleep and circadian rhythm regulation
Sleep Med.
(2007)- et al.
Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat
Pharmacol. Res.
(2002) - et al.
Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus
Eur. J. Pharmacol.
(1980) - et al.
Excessive daytime sleepiness is associated with an exacerbation of migraine: a population-based study
J. Headache Pain
(2016) - et al.
Insomnia in probable migraine: a population-based study
J. Headache Pain
(2016) - et al.
Melanopsin and other novel mammalian opsins
Exp. Eye Res.
(2005)
Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy
Am. J. Med.
Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice
Brain Res.
Exogenous melatonin as a treatment for secondary sleep disorders: a systematic review and meta-analysis
Front. Neuroendocrinol.
Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock
Neuron
Antinociceptive properties of selective MT(2) melatonin receptor partial agonists
Eur. J. Pharmacol.
Is there a role of melatonin in the development of growing pains?
Med. Hypotheses
The mammalian pineal gland: known facts, unknown facets
Trends Endocrinol. Metab.
Treatment outcomes in REM sleep behavior disorder
Sleep Med.
Epidemiology of insomnia: what we know and what we still need to learn
Sleep Med. Rev.
Melatonin: a multitasking molecule
Prog. Brain Res.
International classification of sleep disorders-third edition: highlights and modifications
Chest
Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid
Brain Res. Bull.
Nocturnal polysomnographic sleep across the menstrual cycle in premenstrual dysphoric disorder
Sleep Med.
Prophylaxis of migraine with melatonin: a randomized controlled trial
Neurology
A brief review about melatonin, a pineal hormone
Arch. Endocrinol. Metab.
Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy
Curr. Top. Med. Chem.
Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study
Funct. Neurol.
Prevalence of sleep disorders in childhood and adolescence with headache: a case-control study
Cephalalgia
Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis
BMJ
The circadian system contributes to apnea lengthening across the night in obstructive sleep apnea
Sleep
Melatonin: a major regulator of the circadian rhythm of core temperature in humans
J. Clin. Endocrinol. Metab.
The controversy about spinal neuronal nitric oxide synthase: under which conditions is it up- or downregulated?
Cell Tissue Res.
The role of melatonin in the cells of the innate immunity: a review
J. Pineal Res.
Migraine and somnambulism
Neurology
Association between restless legs syndrome and migraine
J. Neurol. Neurosurg. Psychiatry
Migraine and restless legs syndrome are associated in adults under age fifty but not in adults over fifty: a population-based study
J. Headache Pain
Nocturnal plasma melatonin levels in migraine: a preliminary report
Headache
Melatonin secretion is supersensitive to light in migraine
Cephalalgia
Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening
J. Clin. Sleep Med.
The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature
Nutr. J.
Molecular pharmacology and function of melatonin receptor subtypes
Adv. Exp. Med. Biol.
Use of melatonin versus valproic acid in prophylaxis of migraine patients: a double-blind randomized clinical trial
Restor. Neurol. Neurosci.
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function
Hypertension
Melatonin reduces hyperalgesia associated with inflammation
J. Pineal Res.
A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children
Iran. J. Child Neurol.
Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated
J. Orofac. Pain
The role of melatonin in the treatment of primary headache disorders
Headache
Differential function of melatonin MT1 and MT2 receptors in REM and NREM sleep
Front. Endocrinol. (Lausanne)
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
J. Neurol. Neurosurg. Psychiatry
Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia
J. Pineal Res.
Cited by (9)
Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review
2024, Pharmacological ReportsMigraine in university students: A systematic review and meta-analysis
2023, European Journal of Pain (United Kingdom)Melatonin as a treatment for migraine sufferers: a systematic review
2022, Egyptian Journal of Neurology, Psychiatry and NeurosurgeryResearch progress on the mechanism of comorbidities of vestibular migraine and sleep disorders
2022, Journal of Clinical Otorhinolaryngology Head and Neck Surgery